TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent

NCT00292474 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1326

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: percutaneous coronary intervention

Sponsor

Boston Scientific Corporation